KRAS and colonic neoplasm: Similarly, when the isogenic cell lines SW48 and SW48/KRAS mutant are used for comparison, the observed differences are most likely due to the presence or absence of an oncogenic mutation in KRAS in a colon cancer cell line on the background of functional p53 and an active β-catenin signaling pathway.